Drawing from personal experience, Patty Keating advocates for greater awareness, improved diagnosis, and treatment among ...

News, weather, traffic and more from FOX 5, serving the District of Columbia, Maryland and Virginia. Super Bowl commercials ...

The global hypoparathyroidism treatment market is on the cusp of notable growth, according to a comprehensive analysis conducted by Future Market Insights. In 2022, the market was valued at USD 777.4 ...

Reports Q4 revenue EUR 173.92M vs. EUR 137.7M last year. “Having achieved pivotal milestones in 2024, Ascendis is positioned to continue strong ...

The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...

Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Hypoparathyroidism. ORLANDO, FLORIDA / ACCESSWIRE / February 3, 2025 / The Assistance F ...

Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...

Hypoparathyroidism (hypoPT) is an uncommon condition that happens when your body doesn’t make enough parathyroid hormone (PTH) or the blood levels of PTH are undetectable. How Do You Know If ...

A teenage girl presented to the hospital emergency department with a three-week history of intermittent frontal headache, which was worse in the morning and associated with nausea, vomiting, lethargy, ...

COPENHAGEN - Ascendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company valued at $7.15 billion, has initiated a share ...